Qingxin Mu

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 7

Top Venues

University of Washington

Shandong University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Washington Jun 4o 2017

United States

Research Scientist :: Department of Pharmaceutics

Education History

Shandong University Sep 1o 2005 - Jun 30o 2010

China

PHD :: Pharmaceutical Science

Publications

James Griffin, Yan Wu, Qingxin Mu, Xinyan Li, Rodney J Y Ho
Design and Characterization of a Novel Venetoclax-Zanubrutinib Nano-Combination for Enhancing Leukemic Cell Uptake and Long-Acting Plasma Exposure. Pharmaceutics 15 (3) (2023)
James Griffin, Yan Wu, Qingxin Mu, Xinyan Li, Rodney J Y Ho
Design and Characterization of a Novel Venetoclax-Zanubrutinib Nano-Combination for Enhancing Leukemic Cell Uptake and Long-Acting Plasma Exposure. Pharmaceutics 15 (3) (2023)
James Griffin, Yan Wu, Qingxin Mu, Xinyan Li, Rodney J Y Ho
Design and Characterization of a Novel Venetoclax-Zanubrutinib Nano-Combination for Enhancing Leukemic Cell Uptake and Long-Acting Plasma Exposure. Pharmaceutics 15 (3) (2023)
Zhiyong Wei, Qingxin Mu, Hui Wang, Guanyou Lin, Miqin Zhang
Enzymatic and Cellular Degradation of Carbon-Based Biconcave Nanodisks. Micromachines 13 (7) (2022)
Guanyou Lin, Qingxin Mu, Richard A Revia, Zachary Stephen, Mike Jeon, Miqin Zhang
A highly selective iron oxide-based imaging nanoparticle for long-term monitoring of drug-induced tumor cell apoptosis. Biomaterials science 9 (2) (2021)
Linxi Zhu, Qingxin Mu, Jesse Yu, James I Griffin, Xiaolin Xu, Rodney J Y Ho
ICAM-1 Targeted Drug Combination Nanoparticles Enhanced Gemcitabine-Paclitaxel Exposure and Breast Cancer Suppression in Mouse Models. Pharmaceutics 14 (1) (2021)
Qingxin Mu, Jesse Yu, James I Griffin, Yan Wu, Linxi Zhu, Lisa A McConnachie, Rodney J Y Ho
Novel drug combination nanoparticles exhibit enhanced plasma exposure and dose-responsive effects on eliminating breast cancer lung metastasis. PloS one 15 (3) (2020)

Qingxin Mu.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Qingxin Mu